The severity of SCD complications differ depending on variations in hemoglobin haplotype, HbF, α-thalassemia, Glucose-6-phosphate dehydrogenase deficiency, and UGT1A1 promoter polymorphisms [26]. This evidence concerns the gene UGT1A1 and Schnyder corneal dystrophy.